EoECPH - Homecare Medicines Services

Description

Homecare Medicine Services This framework agreement is for the provision of Homecare Medicines Services to member organisations in the East of England NHS Collaborative Procurement Hub (EOECPH), NHS Commercial Solutions (NHSCS), NHS London Procurement Partnership (NHS LPP), NHS North of England Commercial Procurement Collaborative (NOE CPC) and South East Pharmacy Procurement Service (SEPPS). Whilst focused for the benefit of these organisations, the framework agreement is intended to be available to any publicly funded entities subject to completion of the framework access agreement. The Framework Agreement will be delivered through eight lots which are as follows: Lot 1 - Low Tech Homecare Medicines Service Lot 2 - Mid Tech Homecare Medicines Service Lot 3 - Homecare Medicines Services for Antibiotic Products Lot 4 - High Tech Homecare Medicines Service Lot 5 - Homecare Medicines for Injectable Chemotherapy Lot 6 - Hub and Spoke Controlled Pick-up Model Lot 7 - Homecare Medicines Services for Immunoglobulin Therapies Lot 8 – Homecare Medicines Services for Bleeding Disorders Framework Length: 4 years (no extension options) The questionnaire will run on: The Atamis portal: https://health-family.force.com/s/Welcome How to access the Questionnaire on the portal: • Suppliers should register on the portal, if not already registered: • To access the questionnaire, search and select contract reference – C377794 EoECPH - Homecare Medicines Services. • Please complete the questionnaire within the requirements section • Suppliers can contact the Atamis helpdesk at - support-health@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses Please respond to the questionnaire by no later than 12:00 Midday on Thursday 8 January 2026. Please note that the commissioners/contracting authority/customer / Trusts must not be contacted under any circumstances with regard to this project. All queries must be put through the clarification question process.